Stella Pharma announced that it would cooperate with efforts to promote BNCT at China's 9th China International Import Expo, held from 5 to 10 November in Shanghai, with the aim of raising awareness of BNCT in mainland China and strengthening ties with relevant institutions.
On 27 October, Stella Pharma announced that it regarded the promotion of BNCT in mainland China as an important growth opportunity and would cooperate with BNCT promotion activities during the expo. BNCT refers to boron neutron capture therapy.
Through this initiative, the company aims to raise awareness of BNCT in China, strengthen ties with relevant institutions, and promote the wider adoption of BNCT and the expansion of its business in mainland China.